Dynamic Contrast-enhanced MRI in Renal Tumors: Common Subtype Differentiation using Pharmacokinetics
Abstract Preoperative renal tumor subtype differentiation is important for radiology and urology in clinical practice. Pharmacokinetic data (K trans & V e, etc.) derived from dynamic contrast-enhanced MRI (DCE-MRI) have been used to investigate tumor vessel permeability. In this prospective stud...
Enregistré dans:
Auteurs principaux: | Hai-yi Wang, Zi-hua Su, Xiao Xu, Ning Huang, Zhi-peng Sun, Ying-wei Wang, Lu Li, Ai-tao Guo, Xin Chen, Xin Ma, Lin Ma, Hui-yi Ye |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/aa27053d5f964a738b5cd351a1f8710c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparison.
par: V Lai Nguyen, et autres
Publié: (2013) -
Quantitative estimation of renal function with dynamic contrast-enhanced MRI using a modified two-compartment model.
par: Bin Chen, et autres
Publié: (2014) -
Evaluation of renal quantitative T2* changes on MRI following administration of ferumoxytol as a T2* contrast agent
par: Hedgire SS, et autres
Publié: (2014) -
Assessment of single-vessel cerebral blood velocity by phase contrast fMRI.
par: Xuming Chen, et autres
Publié: (2021) -
Artificially controlled degradable nanoparticles for contrast switch MRI and programmed cancer therapy
par: Yun T, et autres
Publié: (2018)